NOS3 and Mental deterioration: In addition, high levels of endothelial nitric oxide synthase (eNOS) inhibitor asymmetric dimethylarginine (ADMA) in plasma have been linked to an increased risk for endothelial dysfunction associated with cognitive decline [14,15].